Syringes
are needed by doctors to successfully administer various medications to
patients. The limited production of conventional syringes and their reuse by
healthcare practitioners leading to cross-infections gave birth to prefilled
syringes. Conventional syringes are even used by drug addicts to inject
themselves intravenously.
Prefilled
syringes come in predetermined doses or quantities. Some of these devices have
an added self-locking mechanism that kicks in after one use, which prevents
their reuse and protects others from possible infections. These syringes are
currently in high demand due to the high incidence of diabetes and Rheumatoid
Arthritis (RA). Silicone oil is used as a lubricant in the syringes to enhance
their shelf life.
Novel Developments
Scandinavian
Health Limited (SHL) Group, a Swedish manufacturer of autoinjectors and
prefilled syringes, launched two major products targeting RA patients: “Amber
Auto Injector”—a device with customized shapes for gripping the injector—which
would aid RA patients with severe dexterity issues and “Emerade Auto
Injector”—a two-step disposable syringe—which can administer doses in three
strength levels– 150, 300, and 500 micrograms (mcg). It can be used to
administer adrenaline in case of anaphylaxis or emergency. It has reportedly
the longest needle in the market.
The company
has also released an autoinjector (“Molly C”) with an inbuilt data recording
system dubbed “Recording Unit.” This system allows the device to save
patient-related data successfully from their smartphone. It allows users to
post their query on Alubena—a common platform to solve drug-delivery issues related
to the product.
Market Overview
The
worldwide prefilled
syringes market size is expected at USD 22.5 billion by
2025. It is driven by the increasing global use of prefilled syringes and
technological breakthroughs in auto injectors.
Glass
prefilled syringes dominated the global market in 2015, but plastic syringes
segment is anticipated to reign from 2016 to 2025 (forecast period). Diabetes
is predicted to be the largest market application throughout the forecast
period.
Owing to
technological advancements, North America is expected to exhibit high growth
over the forecast period. Some key industry players are Scandinavian Health
Limited (SHL Group), Schott AG, and Unilife Corporation.
In-Depth research report on prefilled
syringes market:
No comments:
Post a Comment